Author response to “lack of benefit from low dose computed tomography in screening for lung cancer”

Abstract

Abstract We explain to Dr. Benjamin (corresponding author) about why low-dose computed tomography reduce lung cancer mortality without significantly reducing all-cause mortality. We also conduct an up-to-date meta-analysis to evaluate low-dose computed tomography clinical effectiveness compared with usual care of lung cancer screening.

Keywords

• Low-dose computed tomography
• LDCT
• Lung cancer screening
• Mortality
• Meta-analysis